Increased levels of endothelin-1 and differential endothelin type A and B receptor expression in scleroderma-associated fibrotic lung disease.
about
Role of endothelin-1 in lung diseasePatient considerations and drug selection in the treatment of idiopathic pulmonary fibrosisMyofibroblasts: trust your heart and let fate decide.Systemic sclerosis: current concepts in pathogenesis and therapeutic aspects of dermatological manifestations.Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patientsThe role of endothelin-1 in the pathogenesis of idiopathic pulmonary fibrosisSystemic vasculopathy with altered vasoreactivity in a transgenic mouse model of scleroderma.BMPR2 mutation alters the lung macrophage endothelin-1 cascade in a mouse model and patients with heritable pulmonary artery hypertension.Constitutive ALK5-independent c-Jun N-terminal kinase activation contributes to endothelin-1 overexpression in pulmonary fibrosis: evidence of an autocrine endothelin loop operating through the endothelin A and B receptors.Systemic sclerosis associated pulmonary hypertension: improved survival in the current era.The current state of biomarkers in systemic sclerosisInhibition of focal adhesion kinase prevents experimental lung fibrosis and myofibroblast formation.Clinical trials in systemic sclerosis: lessons learned and outcomes.Endothelin-1 in systemic sclerosis.Pulmonary Arterial Hypertension-A Deadly Complication of Systemic Sclerosis.Inhibition of endothelin receptors in the treatment of pulmonary arterial hypertension: does selectivity matter?Isolated pulmonary veno-occlusive disease and pulmonary arterial thrombosis in systemic sclerosis - a lethal combination.Knockout of endothelin type B receptor signaling attenuates bleomycin-induced skin sclerosis in miceHow does endothelial cell injury start? The role of endothelin in systemic sclerosis.Vascular dysfunction by myofibroblast activation in patients with idiopathic pulmonary fibrosis and prognostic significance.Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities.Role of host genetics in fibrosis.Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis.Biomarkers in systemic sclerosis.Circulating biomarkers of interstitial lung disease in systemic sclerosis.Gas exchange and pulmonary hypertension following acute pulmonary thromboembolism: has the emperor got some new clothes yet?Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of Systemic Sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension. Myth or reality?Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts.Angiogenesis Dysregulation in the Pathogenesis of Systemic Sclerosis.dsRNA activation of endothelin-1 and markers of vascular activation in endothelial cells and fibroblasts.The cytokine language of monocytes and macrophages in systemic sclerosis.Is macitentan not a treatment option for digital ulcers in systemic sclerosis?Searching for a good model for systemic sclerosis: the molecular profile and vascular changes occurring in UCD-200 chickens strongly resemble the early phase of human systemic sclerosis.Endothelin-1 and transforming growth factor-beta1 independently induce fibroblast resistance to apoptosis via AKT activation.Endothelin-1 induces alveolar epithelial-mesenchymal transition through endothelin type A receptor-mediated production of TGF-beta1TGF-β-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases.T cell repertoire in patients with stable scleroderma
P2860
Q24791936-38040315-EF9E-45EC-B0FD-FFC719B6542FQ26750418-367503A8-B608-422E-8F4F-251FF0DFB34DQ27692541-E7F0FCB1-E37C-43B6-8B5F-CEDA280DA63EQ31125829-817123CC-6A7E-4C7C-9FF5-D923A63AEEA3Q33765684-EE69F545-E6D7-44DF-B520-09BF1EA22D26Q33792303-F82A58CF-3609-4C8A-BEFF-94511ED42F9AQ33923465-A8FD79E4-4208-4BBF-83C7-0642BCF54931Q34180789-A77B7EAA-116B-4F27-9209-DE4C2908FEF7Q35070899-3BE70B62-94BE-45CC-97CC-F08EE7CED327Q35771091-709DC1D1-AA71-406C-8486-C2CB816AABA8Q35896754-E165B5BC-FFB9-440B-8E86-F968785BF569Q35918710-D19D4291-23ED-4303-A083-699BE29D626DQ36130965-6ED5A63A-AAB0-4306-8CF8-80D079BC17CDQ36349660-DBD44180-7DF2-4D9B-8C02-E99E5DAA23FFQ36795578-E58A448A-3945-4591-80E8-C846CE87A234Q36836706-F079D7F8-8FA9-4DD1-8A06-54813A17A417Q36856521-8B1FA636-81C7-4003-A707-DC5FB5FF1259Q36923228-669F015F-E768-4024-A9D1-05EA3AF51B8AQ36927745-0350B930-04FB-4EC7-AAD7-0F5CFFE97BD7Q37371124-05AEC31C-9E53-444E-9110-45E02E44E2E7Q37638268-43CEEE0F-B4F0-4EC9-A88D-3342C084BC9EQ37644559-74243992-A7E9-474D-9F53-B1365165C3A8Q37689681-8A7001E8-941F-48E9-B1F1-3C944054F19FQ37730018-1F32D106-57E2-41A9-908D-6F8CB1F479BAQ38044387-DE78DFED-B444-4CFA-9097-375B55DBCE84Q38227561-00B63C42-2BD9-4A49-9009-3552DF1102E5Q38710580-83F70452-1E6C-4047-8358-5E4095BEE8AEQ40902696-7C3A5590-4CA4-4D9C-9C80-629D37EB9AD5Q41169103-21B3965A-2FAA-4580-BEAF-B368305B7853Q41972569-7E803BED-0CFF-4B9C-9CB2-2691FACCD62AQ42345689-0C56F222-F08E-4DB3-A76B-B223A1E8C264Q42370348-3A46DE6D-E769-4F3C-9D18-BF927229B30CQ42416370-B7C54064-311C-462F-BEF9-4D6D0845EAACQ42560002-3D3F8138-3881-4429-8DD5-4D2EA1FC48A4Q42738467-1F5AF9DD-1263-49D1-BDDC-F6CBAE4B3E4DQ44537770-ADD09E76-29C3-40A1-9839-9ED28D9D4A58Q58659630-606DE381-CA0E-4AD4-A05B-45BE860C93EA
P2860
Increased levels of endothelin-1 and differential endothelin type A and B receptor expression in scleroderma-associated fibrotic lung disease.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Increased levels of endothelin ...... ociated fibrotic lung disease.
@ast
Increased levels of endothelin ...... ociated fibrotic lung disease.
@en
type
label
Increased levels of endothelin ...... ociated fibrotic lung disease.
@ast
Increased levels of endothelin ...... ociated fibrotic lung disease.
@en
prefLabel
Increased levels of endothelin ...... ociated fibrotic lung disease.
@ast
Increased levels of endothelin ...... ociated fibrotic lung disease.
@en
P2093
P2860
P1476
Increased levels of endothelin ...... ociated fibrotic lung disease.
@en
P2093
Abraham DJ
Dashwood MR
Pantelides P
Rajkumar VS
Vancheeswaran R
du Bois RM
P2860
P304
P407
P577
1997-09-01T00:00:00Z